Direct effects of the Asn291Ser variant of the human lipoprotein lipase on the catabolism of VLDL1 and VLDL2 in vivo

被引:0
|
作者
Pietzsch, J
Julius, U
Nitzsche, S
Gehrisch, S
Leonhardt, W
Jaross, W
Hanefeld, M
机构
[1] FAC MED, INST & POLICLIN CLIN METAB RES, DRESDEN, GERMANY
[2] FAC MED, INST CLIN CHEM, DRESDEN, GERMANY
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:26 / 27
页数:2
相关论文
共 6 条
  • [1] Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects
    Malmström, R
    Packard, CJ
    Caslake, M
    Bedford, D
    Stewart, P
    Yki-Järvinen, H
    Shepherd, J
    Taskinen, MR
    DIABETES, 1998, 47 (05) : 779 - 787
  • [2] A systematic review and meta-analysis of the relationship between lipoprotein lipase Asn291Ser variant and diseases
    Hu, Yaomin
    Liu, Wei
    Huang, Rong
    Zhang, Xiaoying
    JOURNAL OF LIPID RESEARCH, 2006, 47 (09) : 1908 - 1914
  • [3] Effects of rosuvastatin on the metabolism of apolipoprotein B of VLDL1, VLDL2, IDL and LDL during type 2 diabetes
    Verges, B.
    Florentin, E.
    Baillot-Rudoni, S.
    Monnier, S.
    Petit, J. M.
    Gambert, P.
    Duvillard, L.
    DIABETES & METABOLISM, 2008, 34 : A37 - A37
  • [4] Liraglutide accelerates the catabolism of apolipoprotein B100 containing lipoproteins (VLDL1, VLDL2, IDL and LDL) in patients with type 2 diabetes: an in vivo kinetic study
    Verges, B.
    Bouillet, B.
    Rouland, A.
    Baillot-Rudoni, S.
    Buffier, P.
    Crevisy, E.
    Petit, J.
    Duvillard, L.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S118 - S118
  • [5] A systematic review and meta-analysis of the relationship between lipoprotein lipase gene Asn291Ser variant and dyslipidaemia
    Liu, W.
    Hu, Y. M.
    DIABETOLOGIA, 2006, 49 : 219 - 220
  • [6] Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects (vol 47, pg 779, 1998)
    Malmström, R
    Packard, C
    Caslake, M
    Bedford, D
    Stewart, P
    Yki-Järvinen, H
    Shepherd, J
    Taskinen, MR
    DIABETES, 1998, 47 (09) : 1532 - 1532